<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="editorial" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1339736</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2023.1339736</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Hot topic: anti-inflammatory drug discovery</article-title>
<alt-title alt-title-type="left-running-head">Silva et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fchem.2023.1339736">10.3389/fchem.2023.1339736</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Silva</surname>
<given-names>Joana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/165158/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bae</surname>
<given-names>Gi-Sang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1582089/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Abdel Moneim</surname>
<given-names>Ahmed Esmat</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/88841/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saeed</surname>
<given-names>Mohd</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1310355/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Adams</surname>
<given-names>James David</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1621427/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ashour</surname>
<given-names>Mohamed L.</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/557905/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Center for Marine and Environmental Sciences (MARE&#x2013;IPLeiria)</institution>, <addr-line>Peniche</addr-line>, <country>Portugal</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Wonkwang University</institution>, <addr-line>Iksan</addr-line>, <country>Republic of Korea</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Helwan University</institution>, <addr-line>Helwan</addr-line>, <country>Egypt</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>University of Hail</institution>, <addr-line>Hail</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Independent Researcher</institution>, <addr-line>Benicia</addr-line>, <country>United States</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Faculty of Pharmacy</institution>, <institution>Ain Shams University</institution>, <addr-line>Cairo</addr-line>, <country>Egypt</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited and Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/187627/overview">Michael Kassiou</ext-link>, The University of Sydney, Australia</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: James David Adams, <email>jadams@usc.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>11</volume>
<elocation-id>1339736</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Silva, Bae, Abdel Moneim, Saeed, Adams and Ashour.</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Silva, Bae, Abdel Moneim, Saeed, Adams and Ashour</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" journal-id="Front. Chem." xlink:href="https://www.frontiersin.org/researchtopic/38574" ext-link-type="uri">Editorial on the Research Topic <article-title>Hot topic: anti-inflammatory drug discovery</article-title>
</related-article>
<kwd-group>
<kwd>plant medicines</kwd>
<kwd>flavonoids</kwd>
<kwd>triterpenes</kwd>
<kwd>opioids</kwd>
<kwd>Benzodiazepines</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Medicinal and Pharmaceutical Chemistry</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>It has been a pleasure to put together this Research Topic on anti-inflammatory drugs. So far, the response has been much better than expected. This Research Topic seems to have had a real impact. Hopefully, the search for new anti-inflammatory drugs will look more closely at the leads suggested here. The treatment of pain and chronic pain with topical preparations is another area that needs more research.</p>
<p>
<italic>Anti-inflammatory sesquiterpene and triterpene acids from Mesona procumbens Hemsley</italic> <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2022.1003356/full">Huang et al.</ext-link> Six triterpene acids were identified and found to have anti-inflammatory activity, including mesoeudesmol. These compounds have been overlooked in the past because of concerns about oral bioavailability. Oral use may improve gut inflammation in diseases such as Crohn&#x2019;s disease. However, recent research has shown that topical treatment of pain and chronic pain is the most effective. Medicines made from this plant might be effective when applied to the skin. The source of these compounds is the plant <italic>M. procumbens</italic> (also known as <italic>Platastoma palustre</italic>), which is used for food and medicine in Asia. The very popular food grass jelly is made from this plant. Triterpene acids will become more important in future healthcare.</p>
<p>
<italic>Potential effect of luteolin, epiafzelechin, and albigenin on rats under cadmium-induced inflammatory insult: In silico and in vivo approach</italic> <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2023.1036478/full">Shahzadi et al.</ext-link> Luteolin, epiafzelechin, and albigenin were found to have anti-inflammatory activity in this study. Luteolin and epiafzelechin are flavonoids, and albigenin is a triterpenoid proanthocyanidin. The source of luteolin is <italic>Senegalia senegal</italic>, gum Arabic, which is used as a food and medicine. The source of albigenin is <italic>Albezia lebbeck</italic>, which is native to India and Southeast Asia where it is used as a traditional medicine. Epiafzelechin comes from <italic>Senegalia chundra</italic>, which is used for timber and medicine. The report details the anti-inflammatory activity of the compounds in a cadmium-based model of inflammation. Additionally, computer modeling data of cyclo-oxygenase 2 binding of the compounds are included.</p>
<p>
<italic>The immunosuppressive effects and mechanisms of loureirin B on collagen-induced arthritis in rats</italic> <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2023.1094649/full">Zou et al.</ext-link> Loureirin B was found to be anti-inflammatory in a rheumatoid arthritis model. The compound is a flavonoid that comes from the traditional Chinese medicine <italic>Dracaena cochinchinensis</italic>. A synthetic procedure was devised for loureirin B and derivatives that were used in the study. Loureirin B was found to decrease the expression of voltage-gated potassium channels Kv 1.3 on effector memory T cells. This resulted in the depression of inflammatory cytokine expression by these cells. Joint swelling and inflammation were found to decrease in a rheumatoid arthritis model. Memory T cells are abundant in the skin and may be of interest in future research.</p>
<p>
<italic>Efficacy and safety analysis of midazolam combined with dezocine sedation and analgesia colonoscopy in patients with inflammatory bowel disease: a prospective single-center open study</italic> <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2023.1150045/full">Chen et al.</ext-link> Midazolam and dezocine provide adequate sedation during colonoscopy. This is useful in a clinical setting where anesthesiologists may not be available. Dezocine is an opioid drug that was discontinued in the United States in 2011 because it causes more respiratory depression than some other opioids. It is used in combination with the benzodiazepine midazolam to induce a twilight sleep type of anesthesia. Dezocine is widely used in China and is considered to be safer than fentanyl, which is the drug of choice in the United States. More than 100,000 patients die from opioids in the United States yearly. A safer approach must be found.</p>
<p>
<italic>A review of FDA approved drugs and their formulations for the treatment of breast cancer</italic> <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2023.1184472/full">Chaurasia et al.</ext-link> This is a thorough review of anti-inflammatory and other drugs used in breast cancer. Breast cancer was diagnosed in 2.3 million women in 2022 and accounted for 685,00 deaths. A useful table of 39 drugs used in breast cancer provides details of each of them. New drug formulations, some of which are in clinical trials, are discussed.</p>
</body>
<back>
<sec id="s1">
<title>Author contributions</title>
<p>JA: Writing&#x2013;original draft. JS: Writing&#x2013;review and editing. G-SB: Writing&#x2013;review and editing. AA: Writing&#x2013;review and editing. MS: Writing&#x2013;review and editing. MA: Writing&#x2013;review and editing.</p>
</sec>
<sec id="s2">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="s3">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s4">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</back>
</article>